Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1981 Jun 1;153(6):1457–1473. doi: 10.1084/jem.153.6.1457

Virus-induced diabetes mellitus. XX. Polyendocrinopathy and autoimmunity

PMCID: PMC2186192  PMID: 6265585

Abstract

Mice infected with reovirus type 1 developed transient diabetes and a runting syndrome. The diabetes was characterized by hyperglycemia, abnormal glucose tolerance tests, and hypoinsulinemia. Inflammatory cells and viral antigens were found in the islets of Langerhans, and virus particles were seen in alpha, beta, and delta cells. The runting syndrome consisted of retarded growth, oily hair, alopecia, and steatorrhea. Inflammatory cells and viral antigens were found in the anterior, but not posterior pituitary. Electron microscopy revealed virus particles in growth hormone (GH)-producing cells and radioimmunoassay showed that the concentration of GH in the blood was decreased. Examination of sera from infected mice revealed autoantibodies that, by immunofluorescence, reacted with cytoplasmic antigens in the islets of Langerhans, anterior pituitary, and gastric mucosa of uninfected mice. Absorption studies and enzyme-linked immunosorbent assays designed to identify the reactive antigens showed that some of the autoantibodies were directed against insulin and others against GH. Reovirus type 3, in contrast to reovirus type 1, did not induce autoantibodies to GH. By use of recombinant viruses, the segment of the reovirus genome responsible for the induction of autoantibodies to GH was identified. Virus containing the S1 gene segment from reovirus type 1, which codes for the sigma 1 polypeptide (i.e., hemagglutinin), infected cells in the anterior pituitary and induced autoantibodies to GH, whereas virus containing the S1 gene segment from reovirus type 3 failed to infect cells in the anterior pituitary and did not induce autoantibodies to GH. We conclude that reovirus type 1 infection can lead to polyendocrinopathy and autoimmunity and that the S1 gene segment is required for the induction of autoantibodies to GH.

Full Text

The Full Text of this article is available as a PDF (2.5 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Binz H., Wigzell H. Horror autotoxicus? Fed Proc. 1978 Aug;37(10):2365–2369. [PubMed] [Google Scholar]
  2. Birge C. A., Peake G. T., Mariz I. K., Daughaday W. H. Radioimmunoassayable growth hormone in the rat pituitary gland: effects of age, sex and hormonal state. Endocrinology. 1967 Aug;81(2):195–204. doi: 10.1210/endo-81-2-195. [DOI] [PubMed] [Google Scholar]
  3. Block M. B., Rosenfield R. L., Mako M. E., Steiner D. F., Rubenstein A. H. Sequential changes in beta-cell function in insulin-treated diabetic patients assessed by C-peptide immunoreactivity. N Engl J Med. 1973 May 31;288(22):1144–1148. doi: 10.1056/NEJM197305312882202. [DOI] [PubMed] [Google Scholar]
  4. Bottazzo G. F., Pouplard A., Florin-Christensen A., Doniach D. Autoantibodies to prolactin-secreting cells of human pituitary. Lancet. 1975 Jul 19;2(7925):97–101. doi: 10.1016/s0140-6736(75)90004-5. [DOI] [PubMed] [Google Scholar]
  5. Catalano M. A., Carson D. A., Niederman J. C., Feorino P., Vaughan J. H. Antibody to the rheumatoid arthritis nuclear antigen. Its relationship to in vivo Epstein-Barr virus infection. J Clin Invest. 1980 May;65(5):1238–1242. doi: 10.1172/JCI109779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chalkley S. R., Tanner J. M. Incidence and effects on growth of antibodies to human growth hormone. Arch Dis Child. 1971 Apr;46(246):160–166. doi: 10.1136/adc.46.246.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Das C., Salahuddin M., Talwar G. P. Investigations on the ability of antisera produced by Pr-beta-HCG-TT to neutralize the biological activity of HCG. Contraception. 1976 Feb;13(2):171–181. doi: 10.1016/0010-7824(76)90029-9. [DOI] [PubMed] [Google Scholar]
  8. Daugharty H., Kelley K., Moore C., Hersh T. Autoimmune implications of immune complexes in clinical variants of hepatitis B. Clin Exp Immunol. 1979 Aug;37(2):213–220. [PMC free article] [PubMed] [Google Scholar]
  9. Dobersen M. J., Scharff J. E., Ginsberg-Fellner F., Notkins A. L. Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus. N Engl J Med. 1980 Dec 25;303(26):1493–1498. doi: 10.1056/NEJM198012253032601. [DOI] [PubMed] [Google Scholar]
  10. Doniach D., Bottazzo G. F. Autoimmunity and the endocrine pancreas. Pathobiol Annu. 1977;7:327–346. [PubMed] [Google Scholar]
  11. Helmke K., Otten A., Willems W. Islet cell antibodies in children with mumps infection. Lancet. 1980 Jul 26;2(8187):211–212. doi: 10.1016/s0140-6736(80)90105-1. [DOI] [PubMed] [Google Scholar]
  12. Irvine W. J., Clarke B. F., Scarth L., Cullen D. R., Duncan L. J. Thyroid and gastric autoimmunity in patients with diabetes mellitus. Lancet. 1970 Jul 25;2(7665):163–168. doi: 10.1016/s0140-6736(70)92531-6. [DOI] [PubMed] [Google Scholar]
  13. Irvine W. J. Classification of idiopathic diabetes. Lancet. 1977 Mar 19;1(8012):638–642. doi: 10.1016/s0140-6736(77)92071-2. [DOI] [PubMed] [Google Scholar]
  14. Knazek R. A., Liu S. C., Graeter R. L., Wright P. C., Mayer J. R., Lewis R. H., Gould E. B., Keller J. A. Growth hormone causes rapid induction of lactogenic receptor activity in the Snell dwarf mouse liver. Endocrinology. 1978 Nov;103(5):1590–1596. doi: 10.1210/endo-103-5-1590. [DOI] [PubMed] [Google Scholar]
  15. Lernmark A., Freedman Z. R., Hofmann C., Rubenstein A. H., Steiner D. F., Jackson R. L., Winter R. J., Traisman H. S. Islet-cell-surface antibodies in juvenile diabetes mellitus. N Engl J Med. 1978 Aug 24;299(8):375–380. doi: 10.1056/NEJM197808242990802. [DOI] [PubMed] [Google Scholar]
  16. NISBET N. W., HESLOP B. F. Runt disease. Br Med J. 1962 Jan 20;1(5272):129–contd. doi: 10.1136/bmj.1.5272.129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Notkins A. L. The causes of diabetes. Sci Am. 1979 Nov;241(5):62–73. doi: 10.1038/scientificamerican1179-62. [DOI] [PubMed] [Google Scholar]
  18. Onodera T., Jenson A. B., Yoon J. W., Notkins A. L. Virus-induced diabetes mellitus: reovirus infection of pancreatic beta cells in mice. Science. 1978 Aug 11;201(4355):529–531. doi: 10.1126/science.208156. [DOI] [PubMed] [Google Scholar]
  19. Panitch H. S., Hooper C. J., Johnson K. P. CSF antibody to myelin basic protein. Measurement in patients with multiple sclerosis and subacute sclerosing panencephalitis. Arch Neurol. 1980 Apr;37(4):206–209. doi: 10.1001/archneur.1980.00500530044005. [DOI] [PubMed] [Google Scholar]
  20. Reinherz E. L., Schlossman S. F. Current concepts in immunology: Regulation of the immune response--inducer and suppressor T-lymphocyte subsets in human beings. N Engl J Med. 1980 Aug 14;303(7):370–373. doi: 10.1056/NEJM198008143030704. [DOI] [PubMed] [Google Scholar]
  21. Schwartz R. S. Epstein-Barr virus--oncogen or mitogen? N Engl J Med. 1980 Jun 5;302(23):1307–1308. doi: 10.1056/NEJM198006053022310. [DOI] [PubMed] [Google Scholar]
  22. Stanley N. F. Reoviruses. Br Med Bull. 1967 May;23(2):150–154. doi: 10.1093/oxfordjournals.bmb.a070536. [DOI] [PubMed] [Google Scholar]
  23. Takeichi N., Kuzumaki N., Kodama T., Sendo F., Hosokawa M. Runting syndrome in rats inoculated with Friend virus. Cancer Res. 1972 Mar;32(3):445–449. [PubMed] [Google Scholar]
  24. Toniolo A., Onodera T., Yoon J. W., Notkins A. L. Induction of diabetes by cumulative environmental insults from viruses and chemicals. Nature. 1980 Nov 27;288(5789):383–385. doi: 10.1038/288383a0. [DOI] [PubMed] [Google Scholar]
  25. Tsoi M. S., Storb R., Jones E., Weiden P. L., Shulman H., Witherspoon R., Atkinson K., Thomas E. D. Deposition of IgM and complement at the dermoepidermal junction in acute and chronic cutaneous graft-vs-host disease in man. J Immunol. 1978 May;120(5):1485–1492. [PubMed] [Google Scholar]
  26. Walters M. L., Stanley N. F., Dawkins R. L., Alpers M. P. Immunological assessment of mice with chronic jaundice and runting induced by reovirus 3. Br J Exp Pathol. 1973 Jun;54(3):329–345. [PMC free article] [PubMed] [Google Scholar]
  27. Weiner H. L., Drayna D., Averill D. R., Jr, Fields B. N. Molecular basis of reovirus virulence: role of the S1 gene. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5744–5748. doi: 10.1073/pnas.74.12.5744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Weiner H. L., Powers M. L., Fields B. N. Absolute linkage of virulence and central nervous system cell tropism of reoviruses to viral hemagglutinin. J Infect Dis. 1980 May;141(5):609–616. doi: 10.1093/infdis/141.5.609. [DOI] [PubMed] [Google Scholar]
  29. Yoon J. W., McClintock P. R., Onodera T., Notkins A. L. Virus-induced diabetes mellitus. XVIII. Inhibition by a nondiabetogenic variant of encephalomyocarditis virus. J Exp Med. 1980 Oct 1;152(4):878–892. doi: 10.1084/jem.152.4.878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Yoon J. W., Onodera T., Notkins A. L. Virus-induced diabetes mellitus. XV. Beta cell damage and insulin-dependent hyperglycemia in mice infected with coxsackie virus B4. J Exp Med. 1978 Oct 1;148(4):1068–1080. doi: 10.1084/jem.148.4.1068. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES